This topic contains a solution. Click here to go to the answer

Author Question: Net present value and internal rate of return capital budgeting decisions can differ because A) ... (Read 42 times)

jlmhmf

  • Hero Member
  • *****
  • Posts: 552
Net present value and internal rate of return capital budgeting decisions can differ because
 
  A) the initial costs of the capital outlays differ.
  B) the cash flow streams differ.
  C) the discount rates differ for different time periods.
  D) All of the above

Question 2

When the exponents of a Cobb-Douglas production function sum to more than 1, the function exhibits
 
  A) constant returns.
  B) increasing returns.
  C) decreasing returns.
  D) either increasing or decreasing returns.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

maaaaaaaaaa

  • Sr. Member
  • ****
  • Posts: 336
Answer to Question 1

D

Answer to Question 2

B




jlmhmf

  • Member
  • Posts: 552
Reply 2 on: Jul 1, 2018
YES! Correct, THANKS for helping me on my review


diana chang

  • Member
  • Posts: 288
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

In 1844, Charles Goodyear obtained the first patent for a rubber condom.

Did you know?

Blastomycosis is often misdiagnosed, resulting in tragic outcomes. It is caused by a fungus living in moist soil, in wooded areas of the United States and Canada. If inhaled, the fungus can cause mild breathing problems that may worsen and cause serious illness and even death.

Did you know?

Always store hazardous household chemicals in their original containers out of reach of children. These include bleach, paint, strippers and products containing turpentine, garden chemicals, oven cleaners, fondue fuels, nail polish, and nail polish remover.

Did you know?

There are approximately 3 million unintended pregnancies in the United States each year.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library